American Parkinson Disease Association Welcomes Two Accomplished Leaders to National Board of Directors

New Board Members Bring Deep Expertise in Health Equity, Policy, and Nonprofit Leadership to APDA NEW YORK, NY, JUNE...see more 10, 2025 โ€” The American Parkinson Disease Association (APDA) is proud to announce the appointment of two distinguished professionals to its National Board of Directors: J. Zoรซ Beckerman, JD, MPH and Adalynn E. Harris, PhD, MPH, […]

Read More

American Parkinson Disease Association Kicks Off 2025 Optimism Walk Series

Across the country, local communities will mobilize in the fight against Parkinsonโ€™s. NEW YORK, NEW YORK, APRIL 7, 2025...see more โ€“ The American Parkinson Disease Association (APDA) is pleased to announce the schedule for the 2025 APDA Optimism Walk series โ€“ a nationwide movement to raise awareness and vital funds for the Parkinsonโ€™s disease (PD) community. […]

Read More

AMERICAN PARKINSON DISEASE ASSOCIATION TO EDUCATE AND EMPOWER DURING PARKINSONโ€™S DISEASE AWARENESS MONTH

APDA helps the Parkinsonโ€™s community live life to the fullest in April and year-round. With a diagnosis every six...see more minutes, public awareness and support are crucial. NEW YORK, NY, MARCH 11, 2025 โ€“ April is Parkinsonโ€™s Disease Awareness Month, and the American Parkinson Disease Association (APDA) will commemorate the month with a โ€œDid You Know?โ€ […]

Read More

FDA Approves New Adaptive DBS System

In exciting news, the FDA approved Medtronicโ€™s deep brain stimulation (DBS) system known...see more as BrainSenseโ„ข. Unlike standard DBS, which delivers electricity to the brain at pre-programmed settings, this technology can sense the brainโ€™s electric signals, known as local field potentials or LFPs, and adjust the stimulation accordingly. This capability, […]

Read More

ONAPGO: A Newly-Approved Medication for OFF Periods in Parkinsonโ€™s

ONAPGOTM: A Newly-Approved Medication for OFF Periods in Parkinsonโ€™s Breaking News! The first subcutaneous (under the skin) apomorphine infusion,...see more now called ONAPGOTM, was approved by the Food and Drug Administration (FDA) on February 4, 2025. Apomorphine is a dopamine agonist whose effects have a rapid onset. It has been available in the US as a […]

Read More

โ€œASK THE DOCTORโ€ WITH DR. REBECCA GILBERT

Q: I was recently told that carbidopa/ levodopa doesnโ€™t help tremor. Is...see more that true? A: No. Carbidopa/levodopa often helps tremor. However, in a certain percentage of people, tremors donโ€™t respond well as other symptoms of PD such as slowness and stiffness. Movement disorder physicians measure whether medication doses […]

Read More